Israel - hebreu - Ministry of Health

merck serono ltd - cetrorelix as acetate - אבקה וממס להכנת תמיסה להזרקה - cetrorelix as acetate 0.25 mg/vial - cetrorelix - cetrorelix - prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques.

Israel - hebreu - Ministry of Health

merck sharp & dohme israel ltd - cilastatin sodium 500 mg/vial; imipenem as monohydrate 500 mg/vial - powder for solution for injection - imipenem and enzyme inhibitor - infections caused by susceptible microorganisms.

Israel - hebreu - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - posaconazole - תרחיף - posaconazole 40 mg/ml - posaconazole - posaconazole - noxafil is indicated for use in the treatment of the following fungal infections in adults : - invasive aspergillosis in patients with disease that is refractory to amphotericin b or itraconazole or in patients who are intolerant of these medicinal products - fusariosis in patients with disease that is refractory to amphotericin b or in patients who are intolerant of amphotericin b - chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole - coccidioidomycosis in patients with disease that is refractory to amphotericin b itraconazole or fluconazole or in patients who are intolerant of these medicinal products - oropharyngeal candidiasis : as first - line therapy in patients who have severe disease or are immunocompromised in whom response to topical therapy is expected to be poor. refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective anti

Israel - hebreu - Ministry of Health

merck sharp & dohme israel ltd - boceprevir 200 mg - capsules - boceprevir - victrelis (boceprevir) is indicated for the treatment of chronic hepatitis c genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients (18 years and older) with compensated liver disease, including cirrhosis, who are previously untreated or who have failed previous interferon and ribavirin therapy.

Israel - hebreu - Ministry of Health

merck sharp & dohme israel ltd - boceprevir 200 mg - capsules - boceprevir - victrelis (boceprevir) is indicated for the treatment of chronic hepatitis c genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients (18 years and older) with compensated liver disease, including cirrhosis, who are previously untreated or who have failed previous interferon and ribavirin therapy.

Israel - hebreu - Ministry of Health

merck sharp & dohme israel ltd - efavirenz 600 mg - film coated tablets - efavirenz - stocrin in combination with other antiretroviral agents, is indicated for the treatment of hiv-1-infection .

Israel - hebreu - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - efavirenz - טבליות מצופות פילם - efavirenz 600 mg - efavirenz - efavirenz - stocrin in combination with other antiretroviral agents, is indicated for the treatment of hiv-1-infection .

Israel - hebreu - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - pneumococcal vaccine polyvalent - תמיסה להזרקה - pneumococcal vaccine polyvalent 25 mcg / 0.5 ml - pneumococcus, purified polysaccharides antigen - pneumococcus, purified polysaccharides antigen - for vaccination against pneumococcal disease caused by those pneumococcal types included in the vaccine.

Israel - hebreu - Ministry of Health

merck serono ltd - cetuximab - תמיסה לאינפוזיה - cetuximab 5 mg/ml - cetuximab - cetuximab - erbitux® is indicated for the treatment of patients with epidermal growth factor receptor (egfr) - expressing, kras wild-type metastatic colorectal cancer• in combination with irinotecan-based chemotherapy• in first-line in combination with folfox• as a single agent in patients who have failed oxaliplatin- and irinotecan-based therapy and who are intolerant to irinotecanerbitux is indicated for the treatment of patients with squamous cell cancer of the head and neck (scchn)• in combination with radiation therapy for locally advanced disease• in combination with platinum-based chemotherapy for recurrent and/or metastatic disease• as a single agent after failure of platinum-based chemotherapy for recurrent and/or metastatic disease

Israel - hebreu - Ministry of Health

merck serono ltd - interferon beta 1a - תמיסה להזרקה - interferon beta 1a 44 mcg/ml - interferon beta-1a - interferon beta-1a - rebif (interferone beta-1a) is indicated for the treatment of patients with relapsing forms of multiple sclerosis to decrease the frequency of clinical exacerbations and delay the accumulation of physical disability. efficacy of rebif in chronic progressive multiple sclerosis has not been established.